I am reading this statement differently... They have stated that a) they have a profitable core that produced $8m EBITDA and $2.8M of free cash flow and, b) gave a forward looking statement that as a group they won't be CF positive until FY21... Also they have >$30M in cash...
My interpretation of this is that they have a core portfolio which will continue to fund the growth in other business units until the tipping point in FY21 - I don't read this and think credit raise... IMO
"In-line with The Group’s long term guidance provided in March 2018 Catapult is on track to generate positive cash flow at the Group level by FY21"
"Core business $8M EBITDA and positive $2.8M cash flow"
- Forums
- ASX - By Stock
- Ann: Full Year Results Presentation
I am reading this statement differently... They have stated that...
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.42 |
Change
0.030(0.88%) |
Mkt cap ! $638.2M |
Open | High | Low | Value | Volume |
$3.41 | $3.51 | $3.34 | $5.142M | 1.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $3.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.47 | 6413 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.980 |
1 | 4986 | 0.970 |
1 | 1036 | 0.965 |
2 | 32659 | 0.960 |
2 | 41512 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 1 | 1 |
1.000 | 42518 | 3 |
1.010 | 10000 | 1 |
1.020 | 25000 | 1 |
1.040 | 18507 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online